Papa & Barkley Cannabis Brand Logo

Papa & Barkley

Data Snapshot: Jun 01, 2026
$1M+

May-2026

Sales

Decline

Trend

6-Month

76

Product Count

SKUs

$34.61

Avg Price

-7.2%

YoY Sales Change

-4.8%

YoY Price Change

Papa & Barkley stands out as California's premier cannabis wellness brand, boasting the top spot in the market for topicals. Famed for their diverse product range, they specialize in CBD-rich balms and tinctures with varied CBD to THC ratios that cater to different therapeutic needs, with sleep and muscle pain relief among them. Also noteworthy is their commitment to transparency, readily providing vital product information for the consumer's scrutiny—evident in their comprehensive batch labels and accessible customer service.
Papa & Barkley Sales

Market Insights Snapshot

Papa & Barkley Historical Sales by Category

Papa & Barkley’s May 2026 category mix remains anchored in Topical at 54.53% share with year-over-year decline of 6.96% and month-over-month dip of 1.08%, while Tincture & Sublingual holds 30.20% share but contracts faster at -10.15% YoY and -8.08% MoM. Edible climbs year-over-year by 31.52% to 10.51% share despite a -4.94% MoM pullback, and Capsules shrink YoY by 31.16% even as they tick up 6.10% MoM to 4.63% share; Concentrates is marginal at 0.12% share with -84.67% YoY and -15.99% MoM. With brand-level sales down 7.17% YoY and average price down 4.81% YoY to $34.61, the mix signals reliance on Topical and Tincture & Sublingual where declines are concentrated, while Edible provides the only YoY offset; the thesis is a defensive mix tilt where growth pockets are too small to counter core-category contraction.

Given a number 1 rank in Topical in California alongside a 6.96% YoY and 1.08% MoM decline in that category, the positioning centers on defending leadership in a softening core while reallocating toward Edible, which rose 31.52% YoY but still sits at 10.51% share. The larger Tincture & Sublingual base at 30.20% share is eroding faster (-10.15% YoY and -8.08% MoM) than Topical, suggesting near-term margin and velocity pressure that price cuts (-4.81% YoY on average price) have not reversed; the implication is that maintaining Topical leadership while accelerating Edible’s contribution by 2–3 share points would be a clearer path to stabilizing total sales than chasing recovery in Tincture & Sublingual, where declines are sharper.

May-2026 Rank
Capsules
Edible
Tincture & Sublingual
Topical
9
28
1
1
3
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Topical
54.5%
$33.89
-7.0%
-1.1%
Tincture & Sublingual
30.2%
$45.72
-10.1%
-8.1%
Edible
10.5%
$19.78
+31.5%
-4.9%
Capsules
4.6%
$54.12
-31.2%
+6.1%
Concentrates
0.1%
$59.19
-84.7%
-16.0%
Papa & Barkley

Competitive Landscape

Papa & Barkley holds rank #1 in CA Topical in May 2026, unchanged from #1 in May 2025, with stability at #1 also across the last three months, indicating a flat rank trajectory while rivals shift around it; Mary's Medicinals sits at #2 with a -31.8% year-over-year sales change, while Liquid Flower climbed from #6 to #4 with a 62.2% year-over-year increase, showing upward pressure from mid-tier movers; additionally, Buddies holds #3 with 33.0% growth versus Sweet ReLeaf (CA) at #5 with a -5.2% decline, suggesting the spread between #1 and the pack is being tested by growth from #3–#4 even as the #2 position contracts; the pattern implies that maintaining #1 will rely on defending against faster-growing challengers rather than overtaking peers, since the lead is stationary while competitors either contract or surge.

Papa & Barkley market ranking for CA Topical

Papa & Barkley

Notable Products

The steepest decline came from CBD/THC 30:1 CBD Rich Releaf Tincture (435mg CBD, 15mg THC, 15ml), down 20.1% month over month and sitting at rank 8, while the category’s other tincture, THC Releaf Oil Tincture (1000mg THC, 15ml), rose 5.4% to rank 7. At the top of the chart, Sleep Releaf- CBD/CBN/THC 1:1:1 Berry Pomegranate Solventless Gummies 20-Pack fell 6.4% but held rank 1, whereas the CBD/THC 1:3 THC Rich Releaf Balm (100mg CBD, 300mg THC, 50ml, 1.7oz) slipped 8.2% to rank 2. Four of the top ten are Topical SKUs, with mixed movements from -8.2% to +14.3% and ranks concentrated at 2, 3, 4, 5, and 6, indicating that Topicals anchor volume despite volatility across sizes. The pattern implies Papa & Barkley is skewing toward high-THC formats and Topicals for dependable rank retention while CBD-dominant tinctures face pullback, suggesting portfolio emphasis on formats with steadier rank resilience rather than low-THC wellness items.

Product
Category
Jan-2026
Feb-2026
Mar-2026
Apr-2026
May-2026
MoM %
Sleep Releaf- CBD/CBN/THC 1:1:1 Berry Pomegranate Solventless Gummies 20-Pack (100mg CBN, 100mg CBD, 100mg THC)
Edible
1
1
1
1
1
-6.4%
CBD/THC 1:3 THC Rich Releaf Balm (100mg CBD, 300mg THC, 50ml, 1.7oz)
Topical
2
2
2
2
2
-8.2%
CBD/THC 3:1 CBD Rich Releaf Balm (135mg CBD, 33mg THC, 15ml)
Topical
3
3
5
4
3
-3.6%
CBD/THC 3:1 CBD Rich Releaf Balm (450mg CBD, 150mg THC, 50ml 1.7oz)
Topical
4
5
4
3
4
-0.8%
CBD/THC 1:3 THC Rich Releaf Body Oil (100mg CBD, 300mg THC, 60ml)
Topical
5
4
6
5
5
+2.1%
CBD/THC 1:3 THC Rich Releaf Balm (30mg CBD, 90mg THC, 15ml, 0.5oz)
Topical
6
6
3
6
6
+14.3%
THC Releaf Oil Tincture (1000mg THC, 15ml)
Tincture & Sublingual
7
7
7
7
7
+5.4%
CBD/THC 30:1 CBD Rich Releaf Tincture (435mg CBD, 15mg THC, 15ml)
Tincture & Sublingual
8
8
8
8
8
-20.1%
CBD/THC 3:1 CBD Rich Releaf Balm (90mg CBD, 30mg THC, 15ml, 0.5oz)
Topical
10
10
10
9
9
+9.7%
Sleep Releaf- CBD/CBG/THC 1:1:1 Pear Apple Recover Gummies 20-Pack (100mg CBD, 100mg CBG, 100mg THC)
Edible
9
9
9
10
10
-4.9%
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market